(Q38341743)

2 September 2017

1 reference

title

Human papillomavirus in the HIV-infected host: epidemiology and pathogenesis in the antiretroviral era. (English)

1 reference

2 September 2017

0 references

0 references

anti-retroviral agent

0 references

author name string

Cristina Brickman

series ordinal

1

1 reference

2 September 2017

Joel M Palefsky

series ordinal

2

1 reference

2 September 2017

publication date

1 March 2015

1 reference

2 September 2017

published in

Current HIV/AIDS reports

1 reference

2 September 2017

volume

12

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

6-15

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-014-0254-4

2 September 2017

exact match

0 references

cites work

Human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Risk of human papillomavirus-associated cancers among persons with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

The spectrum of cancers in West Africa: associations with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

The challenge of AIDS-related malignancies in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Cancer burden in the HIV-infected population in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Trends in anal cancer in Australia, 1982-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Sexual practices, sexually transmitted diseases, and the incidence of anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Sexually transmitted infection as a cause of anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

HIV infection, immunodeficiency, viral replication, and the risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Anal cancers among HIV-infected persons: HAART is not slowing rising incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Impact of the HIV epidemic on the incidence rates of anal cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

The impact of HIV viral control on the incidence of HIV-associated anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Prevalence of HPV infection among females in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Anal human papillomavirus infection in women and its relationship with cervical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Prevalence, Clearance, and Incidence of Anal Human Papillomavirus Infection in HIV‐Infected Men: The HIPVIRG Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Association of cervical SIL and HIV-1 infection among Zimbabwean women in an HIV/STI prevention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Incidence of cervical squamous intraepithelial lesions in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

The papillomavirus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Mucosal junctions: open doors to HPV and HIV infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Papillomavirus genome structure, expression, and post-transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Landscape of genomic alterations in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Low- and high-risk human papillomavirus E7 proteins regulate p130 differently

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Epigenetics and cervical cancer: from pathogenesis to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

HIV infection and the gastrointestinal immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-014-0254-4

Epidemiology and natural history of genital human papillomavirus infection

21 January 2018

1 reference

12 December 2020

Spectrum of HIV/AIDS related cancers in India

1 reference

12 December 2020

The increasing incidence of anal cancer: can it be explained by trends in risk groups?

1 reference

12 December 2020

Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group

1 reference

12 December 2020

Regression of papillomas induced by cottontail rabbit papillomavirus is associated with infiltration of CD8+ cells and persistence of viral DNA after regression.

1 reference

12 December 2020

Correlates of homosexual behavior and the incidence of anal cancer

1 reference

12 December 2020

The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop

1 reference

12 December 2020

Natural history of dysplasia of the uterine cervix

1 reference

12 December 2020

Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.

1 reference

12 December 2020

Antiretroviral therapy and anal cancer: the good, the bad, and the unknown

1 reference

12 December 2020

ACOG Practice Bulletin Number 131: Screening for cervical cancer

1 reference

12 December 2020

High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse

1 reference

12 December 2020

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003

1 reference

12 December 2020

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1 reference

12 December 2020

Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection

1 reference

12 December 2020

Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women

1 reference

12 December 2020

The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts

1 reference

12 December 2020

Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).

1 reference

12 December 2020

Human papillomavirus-associated cancers - United States, 2004-2008.

1 reference

12 December 2020

10.1007/S11904-014-0254-4

Identifiers

DOI

1 reference

2 September 2017

1 reference